| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/02/2000 | EP0975365A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms |
| 02/02/2000 | EP0975361A1 Methods of modulating immune coagulation |
| 02/02/2000 | EP0975360A2 Bovine respiratory and enteric coronovirus as a vaccine |
| 02/02/2000 | EP0975358A2 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3 |
| 02/02/2000 | EP0975354A1 Ligand/lytic peptide compositions and methods of use |
| 02/02/2000 | EP0975353A1 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| 02/02/2000 | EP0975350A1 Use of an extract of alchemilli vulgaris |
| 02/02/2000 | EP0975349A1 Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 02/02/2000 | EP0975347A1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 02/02/2000 | EP0975340A2 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/02/2000 | EP0975327A1 Use of 5ht3 antagonists for promoting intestinal lavage |
| 02/02/2000 | EP0863915B1 Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides |
| 02/02/2000 | EP0767794B1 Phosphinic acid derivatives |
| 02/02/2000 | EP0713529B1 Growth differentiation factor of the TGF-B family |
| 02/02/2000 | EP0558727B1 Bone-growth-stimulating composition |
| 02/02/2000 | CN1243544A Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 02/02/2000 | CN1243439A Use of prumipexole in the treating of restless legs syndrome |
| 02/02/2000 | CN1048986C Heterocyclic compounds and their preparation and use |
| 02/02/2000 | CN1048985C Piperazine derivatives as 5HT1A antagonists |
| 02/01/2000 | US6020510 Cytoprotective compounds |
| 02/01/2000 | US6020477 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzyme |
| 02/01/2000 | US6020366 Butyric acid matrix metalloproteinase inhibitors |
| 02/01/2000 | US6020358 Substituted phenethylsulfones and method of reducing TNFα levels |
| 02/01/2000 | US6020352 Treatment of ischemic disorders of the retina and optic nerve head |
| 02/01/2000 | US6020351 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/01/2000 | US6020350 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals |
| 02/01/2000 | US6020349 Constrained somatostatin agonists and antagonists |
| 02/01/2000 | US6020348 Endothelin receptor antagonists |
| 02/01/2000 | US6020346 Piperidine derivatives having tachykinin antagonist activity |
| 02/01/2000 | US6020345 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine |
| 02/01/2000 | US6020340 Imidazopyridines |
| 02/01/2000 | US6020339 Aryl furan derivatives as PDE IV inhibitors |
| 02/01/2000 | US6020336 Indole and indazole compounds |
| 02/01/2000 | US6020326 Method for inhibition of bone growth by anionic polymers |
| 02/01/2000 | US6020320 Acyl deoxyribonucleoside derivatives and uses thereof |
| 02/01/2000 | US6020315 Preparation having increased in vivo tolerability |
| 02/01/2000 | US6020308 Methods for improving therapeutic effectiveness of treatment of vascularization disorders |
| 02/01/2000 | US6020199 Antisense modulation of PTEN expression |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
| 02/01/2000 | US6020172 Nucleic acid delivery with ovine adenoviral vectors |
| 02/01/2000 | US6020165 Cytikine signal regulators |
| 02/01/2000 | US6019967 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin |
| 02/01/2000 | CA2144947C Serotonin receptor agents |
| 02/01/2000 | CA2109575C Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 02/01/2000 | CA2093798C Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof |
| 01/30/2000 | CA2244554A1 Inhibition of graft versus host disease |
| 01/27/2000 | WO2000004194A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | WO2000004183A1 Bone morphogenic protein |
| 01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004045A1 Axor10, a g-protein coupled receptor |
| 01/27/2000 | WO2000004030A1 Phosphinous and phosphonic acid derivatives used as medicaments |
| 01/27/2000 | WO2000004027A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 01/27/2000 | WO2000004020A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 01/27/2000 | WO2000004019A1 5-bicycloindole compounds |
| 01/27/2000 | WO2000004012A1 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF |
| 01/27/2000 | WO2000004010A1 Bicyclohexane derivatives |
| 01/27/2000 | WO2000004006A1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments |
| 01/27/2000 | WO2000004002A1 Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them |
| 01/27/2000 | WO2000004001A1 Substituted piperazones and their therapeutic uses |
| 01/27/2000 | WO2000004000A1 Piperazinone derivatives and their uses |
| 01/27/2000 | WO2000003996A1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
| 01/27/2000 | WO2000003990A1 Pharmaceutical compositions comprising 2-quinolones |
| 01/27/2000 | WO2000003986A1 Bispiperidines as antithrombotic agents |
| 01/27/2000 | WO2000003981A2 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 01/27/2000 | WO2000003978A2 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 01/27/2000 | WO2000003977A1 Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation |
| 01/27/2000 | WO2000003973A1 Diacylhydrazine derivatives as integrin inhibitors |
| 01/27/2000 | WO2000003711A1 Compounds and compositions for treating tissue ischemia |
| 01/27/2000 | WO2000003709A1 Novel dna-cleaving antitumor agents |
| 01/27/2000 | WO2000003707A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 01/27/2000 | WO2000003706A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 01/27/2000 | WO2000003705A1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 01/27/2000 | WO2000003704A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | WO2000003701A1 Composition for treatment of stress |
| 01/27/2000 | WO2000003700A1 Compositions and methods of treating abnormal cell proliferation |
| 01/27/2000 | WO1999065451A3 Caspases and apoptosis |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | WO1999062503A3 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases |
| 01/27/2000 | WO1999061008A3 Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
| 01/27/2000 | WO1999059609A3 Use of hmg proteins for the preparation of medicaments having cytotoxic activity |
| 01/27/2000 | WO1999058564B1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 01/27/2000 | WO1999056734A3 Transdermal therapeutic system for the administration of candesartan |
| 01/27/2000 | WO1999055388A9 Substituted porphyrins |
| 01/27/2000 | WO1999052925A9 Programmed cell death and caspase-12 |
| 01/27/2000 | WO1999023227A9 Hyaluronan synthase gene and uses thereof |
| 01/27/2000 | DE19918588A1 Piperidinverbindung Piperidine |
| 01/27/2000 | DE19833476A1 New genetically modified, adherently growing CD34-negative stem cells for transfer of gene therapy constructs for treatment of immunodeficiency and metabolic disorders |
| 01/27/2000 | DE19833105A1 New N-amidinophenyl-1-carboxymethyl-4-piperidinepropanamide derivatives useful as antithrombotic, antiaggregatory, antitumor, antimetastatic, antiinflammatory and anti-osteoporosis agents |
| 01/27/2000 | DE19831878A1 New polycyclic thiazolidin-2-ylidene amines, are lipid metabolism regulators useful for treating obesity or type II diabetes |
| 01/27/2000 | DE19828114A1 Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV Prodrugs unstable inhibitors of dipeptidyl peptidase IV |
| 01/27/2000 | CA2343748A1 5-bicycloindole compounds |
| 01/27/2000 | CA2338122A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | CA2338059A1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
| 01/27/2000 | CA2338054A1 Bicyclohexane derivatives |
| 01/27/2000 | CA2338037A1 Compounds specific for the human .alpha.1d adrenergic receptor and uses thereof |
| 01/27/2000 | CA2337997A1 Compounds and compositions for treating tissue ischemia |